Please login to the form below

Not currently logged in
Email:
Password:

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

IFPMA has appointed Helen Gallagher as  its new communications director, a role that will see her act as a key spokesperson for the global biopharmaceutical industry trade body in its interaction with stakeholders and the wider global health community.

She said: “I look forward to getting the message out there of the many contributions that the R&D-based biopharmaceutical industry had made, and will make, to improve public health and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.

“I look forward to working with the IFPMA team to help strengthen the industry voice, build bridges among diverse global health actors, champion solutions and demonstrate that we are an essential partner in resolving health problems globally.”

Prior to her new role at IFPMA, Gallagher headed the corporate communications position at Ferring Pharmaceuticals for 12 years and she was also responsible for its corporate social responsibility programme and led its CSR taskforce.

Her 20-year career in health and biopharmaceutical communications has seen her serve in numerous capacities for Manning Selvage & Lee, Cohn & Wolfe, The Rowland Company and Ciba Speciality Chemicals.

Thomas Cueni, director general, IFPMA, said: “Helen will be instrumental in articulating our value proposition, building partnership and alliances, and representing our industry in discussions with permanent missions to the United Nations, intergovernmental organisations and other non-governmental organisations, foundations and academic institutions.”

13th November 2017

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics